Silodosin Patent Expiration
Silodosin is Used for managing the signs and symptoms of benign prostatic hyperplasia (BPH). It was first introduced by Allergan Sales Llc
Silodosin Patents
Given below is the list of patents protecting Silodosin, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Rapaflo | US5387603 | 1,5,7-trisubstituted indoline compounds and salts thereof |
Dec 01, 2018
(Expired) | Allergan |
Rapaflo | US5403847 | Use of α1C specific compounds to treat benign prostatic hyperlasia |
Nov 13, 2012
(Expired) | Allergan |
Rapaflo | US5780485 | Use of α1c specific compounds to treat benign prostatic hyperplasia |
Nov 13, 2012
(Expired) | Allergan |
Rapaflo | US6015819 | Use of alpha-1C specific compounds to treat benign prostatic hyperplasia |
Nov 13, 2012
(Expired) | Allergan |
Try Our Curated Drug Screens
Silodosin Generics
Several generic applications have been filed for Silodosin. The first generic version for Silodosin was by Chartwell Rx Sciences Llc and was approved on Mar 31, 2017. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Dec 8, 2022.
Given below is the list of companies who have filed for Silodosin generic.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
4MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
8MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
2. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
8MG | capsule | Discontinued | ORAL | N/A | Nov 22, 2019 |
4MG | capsule | Discontinued | ORAL | N/A | Nov 22, 2019 |
3. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
8MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
4MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
4. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
4MG | capsule | Prescription | ORAL | AB | Dec 10, 2018 |
8MG | capsule | Prescription | ORAL | AB | Dec 10, 2018 |
5. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
4MG | capsule | Prescription | ORAL | AB | Mar 31, 2017 |
8MG | capsule | Prescription | ORAL | AB | Mar 31, 2017 |
6. CREEKWOOD PHARMS
Creekwood Pharmaceuticals Llc has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Creekwood Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
8MG | capsule | Prescription | ORAL | AB | Jan 3, 2022 |
4MG | capsule | Prescription | ORAL | AB | Jan 3, 2022 |
7. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
4MG | capsule | Prescription | ORAL | AB | Feb 14, 2020 |
8MG | capsule | Prescription | ORAL | AB | Feb 14, 2020 |
8. LUPIN LTD
Lupin Ltd has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
4MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
8MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
9. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
4MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
8MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
10. MSN
Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Msn.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
4MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
8MG | capsule | Prescription | ORAL | AB | Dec 3, 2018 |
11. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Prinston Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
4MG | capsule | Prescription | ORAL | AB | Jan 4, 2022 |
8MG | capsule | Prescription | ORAL | AB | Jan 4, 2022 |
12. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Silodosin. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
8MG | capsule | Discontinued | ORAL | N/A | Dec 8, 2022 |
4MG | capsule | Discontinued | ORAL | N/A | Dec 8, 2022 |